Drug Approval | February 15, 2022
Avion Pharmaceuticals announces USFDA approval of DHIVY
Parkinson's disease treatment is the first and only carbidopa/levodopa (CD/LD) tablet designed to be divided for precise dosing
Parkinson's disease treatment is the first and only carbidopa/levodopa (CD/LD) tablet designed to be divided for precise dosing
These results will be presented on 17 February at the 2022 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium
Key takeaways of Q3FY22 quarter & conference call highlights
Launches a host of innovative products & solutions across the entire flexible packaging value chain in October - December 2021
The KRIVIDA Novus RT-PCR kit can detect the Omicron variant, its sub-lineages, and the Delta variant in 45 minutes
Expected to open later this year, the facility will significantly increase distribution capacity to meet the growing demand for production materials by Ireland's biopharma industry
The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad
Key takeaways of recent quarter & conference call highlights
It will showcase the company’s latest technologies in robotics, digital health and orthopaedic implants
Adds five years of market exclusivity on approval
Subscribe To Our Newsletter & Stay Updated
